OliX Pharmaceuticals, Inc (KOSDAQ:226950)
122,400
-9,700 (-7.34%)
At close: Feb 6, 2026
549.34% (1Y)
| Market Cap | 2.47T +752.7% |
| Revenue (ttm) | 10.18B -36.9% |
| Net Income | -43.30B |
| EPS | -2,280.15 |
| Shares Out | 20.19M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 476,537 |
| Average Volume | 513,745 |
| Open | 120,800 |
| Previous Close | 132,100 |
| Day's Range | 118,000 - 126,000 |
| 52-Week Range | 16,500 - 161,000 |
| Beta | 0.55 |
| RSI | 41.00 |
| Earnings Date | Mar 20, 2026 |